Literature DB >> 16081600

In vivo rescue of defective memory CD8+ T cells by cognate helper T cells.

Udayasankar Kumaraguru1, Kaustuv Banerjee, Barry T Rouse.   

Abstract

The magnitude and efficacy of CD8(+) T cell memory may notably regress, especially if immune induction occurs in the absence of adequate CD4(+) help. This report demonstrates that this CD8(+) memory malfunction could be remedied if a source of cognate antigen-recognizing helper cells were provided during recall. The inability of adoptive transfer of memory SIINFEKL-specific CD8 cells to reject tumors was overcome if recipients were primed for ovalbumin-specific helper cell responses. Additionally, animals primed for a SIINFEKL-specific memory response and incapable of rejecting the tumor could regain protective immunity if given helper cells. This pattern of CD8(+) T cell functional rescue or reprogramming by helper cell transfer was replicated using a Herpes simplex virus antiviral immunity system. Our results could mean that therapeutic vaccine approaches could be designed to compensate situations that have defective CD8(+) T cell function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16081600     DOI: 10.1189/jlb.0105007

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  10 in total

Review 1.  The potential of CD4 T-cell memory.

Authors:  K Kai McKinstry; Tara M Strutt; Susan L Swain
Journal:  Immunology       Date:  2010-03-16       Impact factor: 7.397

Review 2.  Induction and function of virus-specific CD4+ T cell responses.

Authors:  Jason K Whitmire
Journal:  Virology       Date:  2011-01-14       Impact factor: 3.616

3.  SA-4-1BBL as the immunomodulatory component of a HPV-16 E7 protein based vaccine shows robust therapeutic efficacy in a mouse cervical cancer model.

Authors:  Rajesh K Sharma; Abhishek K Srivastava; Esma S Yolcu; Kathryn J MacLeod; Rich-Henry Schabowsky; Shravan Madireddi; Haval Shirwan
Journal:  Vaccine       Date:  2010-07-04       Impact factor: 3.641

4.  Dexamethasone attenuates development of monocrotaline-induced pulmonary arterial hypertension.

Authors:  Wei Wang; Yu-Lin Wang; Xiao-Ying Chen; Yu-Tang Li; Wei Hao; You-Peng Jin; Bo Han
Journal:  Mol Biol Rep       Date:  2011-03-23       Impact factor: 2.316

5.  Selective antigen-specific CD4(+) T-cell, but not CD8(+) T- or B-cell, tolerance corrupts cancer immunotherapy.

Authors:  Adam E Snook; Michael S Magee; Stephanie Schulz; Scott A Waldman
Journal:  Eur J Immunol       Date:  2014-05-21       Impact factor: 5.532

Review 6.  Viral vaccines and CTL response.

Authors:  Stacie N Woolard; Uday Kumaraguru
Journal:  J Biomed Biotechnol       Date:  2010-03-31

Review 7.  Shaping successful and unsuccessful CD8 T cell responses following infection.

Authors:  Maureen A Cox; Allan J Zajac
Journal:  J Biomed Biotechnol       Date:  2010-03-31

8.  Natural killer cells as novel helpers in anti-herpes simplex virus immune response.

Authors:  Subhadra Nandakumar; Stacie N Woolard; Dorothy Yuan; Barry T Rouse; Uday Kumaraguru
Journal:  J Virol       Date:  2008-08-20       Impact factor: 5.103

9.  Vaccination with embryonic stem cells protects against lung cancer: is a broad-spectrum prophylactic vaccine against cancer possible?

Authors:  Kavitha Yaddanapudi; Robert A Mitchell; Kalyani Putty; Sharon Willer; Rajesh K Sharma; Jun Yan; Haribabu Bodduluri; John W Eaton
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

10.  Generation in vivo of peptide-specific cytotoxic T cells and presence of regulatory T cells during vaccination with hTERT (class I and II) peptide-pulsed DCs.

Authors:  Mark M Aloysius; Alastair J Mc Kechnie; Richard A Robins; Chandan Verma; Jennifer M Eremin; Farzin Farzaneh; Nagy A Habib; Joti Bhalla; Nicola R Hardwick; Sukchai Satthaporn; Thiagarajan Sreenivasan; Mohammed El-Sheemy; Oleg Eremin
Journal:  J Transl Med       Date:  2009-03-19       Impact factor: 5.531

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.